Cargando…
Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study
OBJECTIVES: The Simplified Disease Activity Index (SDAI) is a recommended composite score for assessing the remission status in patients with rheumatoid arthritis (RA). However, determination of C-reactive protein (CRP) levels takes several hours and sometimes days and limits the use of the SDAI in...
Autores principales: | Schally, Julia, Brandt, Henning Christian, Brandt-Jürgens, Jan, Burmester, Gerd R., Haibel, Hildrun, Käding, Henriette, Karberg, Kirsten, Lüders, Susanne, Muche, Burkhard, Protopopov, Mikhail, Rios Rodriguez, Valeria, Torgutalp, Murat, Verba, Maryna, Zinke, Silke, Poddubnyy, Denis, Proft, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393358/ https://www.ncbi.nlm.nih.gov/pubmed/36003590 http://dx.doi.org/10.1177/1759720X221114107 |
Ejemplares similares
-
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022) -
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022) -
The MIDAS SDAI implementation
por: Thomas, D, et al.
Publicado: (1996) -
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022) -
Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
por: Proft, Fabian, et al.
Publicado: (2021)